NeuroStar TMS Therapy is FDA-cleared for adult patients 22 and over with major depressive disorder (MDD) who have not had success with antidepressant medication. NeuroStar is covered by most insurance companies, including Medicare.
TMS, or transcranial magnetic stimulation, is a safe and non-invasive treatment for depression that uses magnetic pulses to stimulate nerve cells and reactivate regions of the brain with decreased activity. In addition to being FDA-cleared to treat qualified adult patients with major depressive disorder (MDD), NeuroStar is also FDA-cleared to treat obsessive-compulsive disorder (OCD), and anxious depression.
Clinical data provides evidence that when used as an adjunct, NeuroStar Advanced TMS Therapy is safe and effective for adolescents aged 15 and older with MDD as well.
Chrysalis Psychiatry uses NeuroStar Advanced Therapy, the #1 physician-recommended TMS technology. A study showed 83 percent of patients experienced significant improvement in depressive symptoms, and 62 percent felt full remission from depression (Sackeim HA, et al. (2020). J Affect Disord, 277:65 74. Based on a real-world, retrospective study using CGI-S and a sample size of 615 patients).
TMS Therapy is conducted while you are awake, with small magnetic coils positioned against your head. You may feel sensations of tapping, tingling, or warming, but these are usually temporary and subside as you continue treatments. Each session takes less than 20 minutes and is administered five days a week for approximately seven weeks. There is no downtime required after treatment, so you will be able to return to your normal routine immediately after your appointment.
FDA clearance is a label you may see when researching a product, procedure, or technology. While many understand FDA clearance as a positive thing, the specific parameters an entity must meet to receive this clearance are not always well known or understood. This label is given by the U.S. Food and Drug Administration, or FDA a government organization responsible for protecting the health of the United States by ensuring the safety, efficacy, and security of products.
As part of the clearance process, the FDA thoroughly examines research, data, and evidence to determine whether a product is safe and effective for public use. They also need to prove that a product’s potential benefits outweigh its risks. NeuroStar Advanced TMS Therapy has undergone this extensive evaluation process and has been deemed safe, effective, and beneficial by the FDA for the specific mental health problems mentioned above.
At Chrysalis Psychiatry, our clinical team is dedicated to providing you with comprehensive mental health care using innovative solutions to manage and treat symptoms of depressive disorder. One of our keystone approaches is TMS Therapy using the NeuroStar system. This technology is clinically proven to treat depression, especially when other treatments have not been successful. Contact our office today to learn how the FDA-cleared NeuroStar System could help lift the weight of depression and support your journey toward a happier life.
